CAV1 and neoplasm: The co-injection of Cav1-deficient dermal fibroblasts with melanoma cells is sufficient to recapitulate the tumor phenotype observed in Cav1-null mice as the Cav1-null fibroblasts promoted the growth of melanoma cells via enhanced paracrine cytokine signaling [113].